Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Adicionar filtros








Intervalo de ano
3.
Indian Heart J ; 1994 Jan-Feb; 46(1): 21-4
Artigo em Inglês | IMSEAR | ID: sea-3486

RESUMO

Two hundred and forty four newly diagnosed hypertensives (cases) of age 40 years and above, attending the hypertensive clinic of the Government General Hospital during one year and three hundred and twelve normotensives (controls) belonging to the same age group and attending the outpatient department during the same period for other minor ailments formed the subjects for this case control study. There were 18 (7.4%) obese subjects among hypertensives and 6 (1.9%) among controls. In spite of these low proportions, there was a strong association between obesity and hypertension with an overall odds ratio of 4 and there appeared to be a significant increasing trend in the proportion of cases of hypertension (37%, 63%, 75%) observed according to the different grades (underweight or normal, overweight, obese) of nutrition.


Assuntos
Adulto , Estudos de Casos e Controles , Feminino , Humanos , Hipertensão/complicações , Índia/epidemiologia , Masculino , Pessoa de Meia-Idade , Obesidade/complicações
4.
Artigo em Inglês | IMSEAR | ID: sea-88369

RESUMO

The effect of a single dose of intermediate acting (Lente) insulin given subcutaneously at 9.00 P.M. in 22 NIDDM subjects refractory to a combination of Sulphonylureas and Biguanides was analysed. Euglycemia was achieved and maintained during the study period of three months with a mean insulin requirement of 14.22 +/- 5.98 units/day. Plasma FFA, Total cholesterol, triglyceride and VLDL-cholesterol also showed significant reduction. The level of FFA modulates hepatic glucose production, which in turn correlates positively with the fasting blood glucose. The therapeutic modality of bed time Lente Insulin based on physiological principles is an effective way of achieving glycemic control in NIDDM subjects who have become non-responsive to oral hypoglycemic agents.


Assuntos
Biguanidas/administração & dosagem , Glicemia/análise , Clorpropamida/administração & dosagem , Diabetes Mellitus Tipo 2/sangue , Combinação de Medicamentos , Feminino , Glipizida/administração & dosagem , Glibureto/administração & dosagem , Hemoglobinas Glicadas/análise , Humanos , Injeções Subcutâneas , Insulina de Ação Prolongada/administração & dosagem , Lipídeos/sangue , Masculino , Metformina/administração & dosagem , Pessoa de Meia-Idade , Fenformin/administração & dosagem , Compostos de Sulfonilureia/administração & dosagem , Fatores de Tempo
5.
Bull Indian Inst Hist Med Hyderabad ; 1981 ; 1-4(): 64-74
Artigo em Inglês | IMSEAR | ID: sea-1854
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA